Диссертация (1141192), страница 17
Текст из файла (страница 17)
Lee [еt al.] // Clin. Pharmacol. – 2003. – Vol. 43.– P.84-91.181. Tramadol efficacy in patients with postoperative pain in relationto CYP2D6 and MDR1 polymorphisms [Теxt] / O. Slanar [еt al.] // Bratisl LekListy. – 2012. – Vol.113, №3. – P.152-155.182. Watson, J.D.
Molecular structure of nucleic acids [Теxt] / J.D.Watson, F.H.C. Crick // Nature. – 1953. – Vol. 171. – P.738-740.183. Weinshilboum, R. Inheritance and drug response [Теxt] / R.Weinshilboum // N Engl J Med. – 2003. – Vol. 348. – P.529-537.184. White, P.F. Improving postoperative pain management: what arethe unresolved issues? [Теxt] / P.F. White, H. Kehlet // Anesthesiology. – 2010.– Vol.112, №1.
– P.220–225.185. Yiannakopoulou, E. Pharmacogenomics and opioid analgesics:clinical implications [Теxt] / E. Yiannakopoulou // Int J Genomics. – 2015;2015: 368979. doi: 10.1155/2015/368979186. Young, J. Pediatric proteomics: an introduction [Теxt] / J. Young,W.L. Stone // Front Biosci. – 2012. – Vol. 4. – P.1078-1087.187.Zahari, Z. Influence of Cytochrome P450, Family 2, SubfamilyD, Polypeptide 6 (CYP2D6) polymorphisms on pain sensitivity and clinical response to weak opioid analgesics [Text] / Z. Zahari, R. Ismail // Drug MetabPharmacokinet.
– 2014. – Vol. 29, №1. – P.29-43.105188. Zineh, I. Biomarkers in drug development and regulation: a paradigm for clinical implementation of personalized medicine [Теxt] / I. Zineh,S.M. Huang // Biomark Med. – 2011. – Vol. 5, № 6. – P.705-707106.